{"id":"https://openalex.org/W4281746906","doi":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206","title":"Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study","display_name":"Development and Validation of the HPLC Method for Quantification of the Innovative Drug DD217, Factor Xa Inhibitor, in Rat Plasma for a Pharmacokinetic Study","publication_year":2022,"publication_date":"2022-05-30","ids":{"openalex":"https://openalex.org/W4281746906","doi":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206"},"language":"en","primary_location":{"id":"doi:10.33380/2305-2066-2022-11-2-197-206","doi":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206","pdf_url":"https://www.pharmjournal.ru/jour/article/download/1235/983","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development &amp; registration","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4281746906"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"diamond","oa_url":"https://www.pharmjournal.ru/jour/article/download/1235/983","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5082621888","display_name":"N. S. Dubovik","orcid":"https://orcid.org/0000-0002-6171-2496","observed_orcids":["https://orcid.org/0000-0002-6171-2496"]},"institutions":[{"id":"https://openalex.org/I887846188","display_name":"National Research Nuclear University MEPhI","ror":"https://ror.org/04w8z7f34","country_code":"RU","type":"education","lineage":["https://openalex.org/I887846188"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"N. S. Dubovik","raw_affiliation_strings":["National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)"],"raw_orcid":"https://orcid.org/0000-0002-6171-2496","affiliations":[{"raw_affiliation_string":"National Research Nuclear University MEPhI (Moscow Engineering Physics Institute)","institution_ids":["https://openalex.org/I887846188"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070475475","display_name":"Dorel T. Guranda","orcid":"https://orcid.org/0000-0001-7500-6122","observed_orcids":["https://orcid.org/0000-0001-7500-6122"]},"institutions":[{"id":"https://openalex.org/I19880235","display_name":"Lomonosov Moscow State University","ror":"https://ror.org/010pmpe69","country_code":"RU","type":"education","lineage":["https://openalex.org/I19880235"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"D. F. Guranda","raw_affiliation_strings":["LLC \"Pharm InnTech\"; A. N. Belozersky Research Institute of Physical-Chemical Biology, Lomonosov Moscow State University"],"raw_orcid":"https://orcid.org/0000-0001-7500-6122","affiliations":[{"raw_affiliation_string":"LLC \"Pharm InnTech\"; A. N. Belozersky Research Institute of Physical-Chemical Biology, Lomonosov Moscow State University","institution_ids":["https://openalex.org/I19880235"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029949452","display_name":"Galina Vladislavovna Ramenskaya","orcid":"https://orcid.org/0000-0001-8779-3573","observed_orcids":["https://orcid.org/0000-0001-8779-3573"]},"institutions":[{"id":"https://openalex.org/I17877952","display_name":"Sechenov University","ror":"https://ror.org/02yqqv993","country_code":"RU","type":"education","lineage":["https://openalex.org/I17877952"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"G. V. Ramenskaya","raw_affiliation_strings":["I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)"],"raw_orcid":"https://orcid.org/0000-0001-8779-3573","affiliations":[{"raw_affiliation_string":"I. M. Sechenov First MSMU of the Ministry of Health of the Russian Federation (Sechenov University)","institution_ids":["https://openalex.org/I17877952"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059036171","display_name":"Dmitry G. Tovbin","orcid":"https://orcid.org/0000-0002-9917-0469","observed_orcids":["https://orcid.org/0000-0002-9917-0469"]},"institutions":[{"id":"https://openalex.org/I2801076587","display_name":"Semenov Institute of Chemical Physics","ror":"https://ror.org/01jemb993","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I2801076587","https://openalex.org/I4210145551"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"D. G. Tovbin","raw_affiliation_strings":["LLC \"PharmaDiall\"; N. N. Semenov Institute of Chemical Physics"],"raw_orcid":"https://orcid.org/0000-0002-9917-0469","affiliations":[{"raw_affiliation_string":"LLC \"PharmaDiall\"; N. N. Semenov Institute of Chemical Physics","institution_ids":["https://openalex.org/I2801076587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073170745","display_name":"Dmitry N. Tarasov","orcid":"https://orcid.org/0000-0002-8106-9960","observed_orcids":["https://orcid.org/0000-0002-8106-9960"]},"institutions":[{"id":"https://openalex.org/I2801076587","display_name":"Semenov Institute of Chemical Physics","ror":"https://ror.org/01jemb993","country_code":"RU","type":"facility","lineage":["https://openalex.org/I1313323035","https://openalex.org/I2801076587","https://openalex.org/I4210145551"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"D. N. Tarasov","raw_affiliation_strings":["LLC \"PharmaDiall\"; N. N. Semenov Institute of Chemical Physics"],"raw_orcid":"https://orcid.org/0000-0002-8106-9960","affiliations":[{"raw_affiliation_string":"LLC \"PharmaDiall\"; N. N. Semenov Institute of Chemical Physics","institution_ids":["https://openalex.org/I2801076587"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034249553","display_name":"Alla Yu. Savchenko","orcid":"https://orcid.org/0000-0003-2734-5036","observed_orcids":["https://orcid.org/0000-0003-2734-5036"]},"institutions":[{"id":"https://openalex.org/I64264942","display_name":"Federal Medical-Biological Agency","ror":"https://ror.org/052ay8m85","country_code":"RU","type":"government","lineage":["https://openalex.org/I64264942"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"A. Yu. Savchenko","raw_affiliation_strings":["Scientific Center for Biomedical Technologies of the Federal Medical and Biological Agency"],"raw_orcid":"https://orcid.org/0000-0003-2734-5036","affiliations":[{"raw_affiliation_string":"Scientific Center for Biomedical Technologies of the Federal Medical and Biological Agency","institution_ids":["https://openalex.org/I64264942"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055535820","display_name":"\u0410\u0440\u043d\u0430\u0443\u0442\u043e\u0432 \u0412\u043b\u0430\u0434\u0438\u043c\u0438\u0440 \u0421\u0435\u0440\u0433\u0435\u0435\u0432\u0438\u0447","orcid":"https://orcid.org/0000-0003-3554-8941","observed_orcids":["https://orcid.org/0000-0003-3554-8941"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. S. Arnautov","raw_affiliation_strings":["LLC \"PharmaDiall\""],"raw_orcid":"https://orcid.org/0000-0003-3554-8941","affiliations":[{"raw_affiliation_string":"LLC \"PharmaDiall\"","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"11","issue":"2","first_page":"197","last_page":"206"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.9916999936103821,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.004900000058114529,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10800","display_name":"Forensic Toxicology and Drug Analysis","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-xa-inhibitors","display_name":"factor Xa inhibitors","score":0.8510000109672546},{"id":"https://openalex.org/keywords/anticoagulants","display_name":"anticoagulants","score":0.9350000023841858},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9160000085830688},{"id":"https://openalex.org/keywords/rat-plasma","display_name":"rat plasma","score":0.8199999928474426},{"id":"https://openalex.org/keywords/hplc-ms-ms-method-validation","display_name":"HPLC-MS/MS method validation","score":0.9419999718666077},{"id":"https://openalex.org/keywords/intragastric-administration","display_name":"intragastric administration","score":0.8090000152587891},{"id":"https://openalex.org/keywords/pharmacokinetic-parameters","display_name":"pharmacokinetic parameters","score":0.6930000185966492},{"id":"https://openalex.org/keywords/therapeutic-drug-monitoring","display_name":"therapeutic drug monitoring","score":0.47600001096725464},{"id":"https://openalex.org/keywords/wistar-rats","display_name":"Wistar rats","score":0.5759999752044678},{"id":"https://openalex.org/keywords/matrix-effects","display_name":"matrix effects","score":0.5099999904632568},{"id":"https://openalex.org/keywords/carryover","display_name":"carryover","score":0.5699999928474426},{"id":"https://openalex.org/keywords/stability","display_name":"stability","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C43617362","wikidata":"https://www.wikidata.org/wiki/Q170050","display_name":"Chromatography","level":1,"score":0.8093240857124329},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7093650698661804},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7047216892242432},{"id":"https://openalex.org/C2777379063","wikidata":"https://www.wikidata.org/wiki/Q161233","display_name":"Formic acid","level":2,"score":0.6202970743179321},{"id":"https://openalex.org/C179998833","wikidata":"https://www.wikidata.org/wiki/Q381233","display_name":"High-performance liquid chromatography","level":2,"score":0.6010153293609619},{"id":"https://openalex.org/C40684141","wikidata":"https://www.wikidata.org/wiki/Q902061","display_name":"Electrospray ionization","level":3,"score":0.5177173018455505},{"id":"https://openalex.org/C73826308","wikidata":"https://www.wikidata.org/wiki/Q684907","display_name":"Elution","level":2,"score":0.4289438724517822},{"id":"https://openalex.org/C162356407","wikidata":"https://www.wikidata.org/wiki/Q180809","display_name":"Mass spectrometry","level":2,"score":0.32551953196525574},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3206503391265869},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.07095983624458313}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.33380/2305-2066-2022-11-2-197-206","doi":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206","pdf_url":"https://www.pharmjournal.ru/jour/article/download/1235/983","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development &amp; registration","raw_type":"journal-article"},{"id":"pmh:oai:doaj.org/article:3e881671b4de4b3392f1ba2a7978d859","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/3e881671b4de4b3392f1ba2a7978d859","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"\u0420\u0430\u0437\u0440\u0430\u0431\u043e\u0442\u043a\u0430 \u0438 \u0440\u0435\u0433\u0438\u0441\u0442\u0440\u0430\u0446\u0438\u044f \u043b\u0435\u043a\u0430\u0440\u0441\u0442\u0432\u0435\u043d\u043d\u044b\u0445 \u0441\u0440\u0435\u0434\u0441\u0442\u0432, Vol 11, Iss 2, Pp 197-206 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.33380/2305-2066-2022-11-2-197-206","doi":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206","is_oa":true,"landing_page_url":"https://doi.org/10.33380/2305-2066-2022-11-2-197-206","pdf_url":"https://www.pharmjournal.ru/jour/article/download/1235/983","source":{"id":"https://openalex.org/S4210178334","display_name":"Drug development & registration","issn_l":"2305-2066","issn":["2305-2066","2658-5049"],"is_oa":true,"is_in_doaj":true,"is_core":false,"listed_in":["doaj","poland-20","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug development &amp; registration","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4281746906.pdf","grobid_xml":"https://content.openalex.org/works/W4281746906.grobid-xml"},"referenced_works_count":11,"referenced_works":["https://openalex.org/W2106871128","https://openalex.org/W2566682829","https://openalex.org/W2583679349","https://openalex.org/W2616300024","https://openalex.org/W2622470534","https://openalex.org/W2788619470","https://openalex.org/W2790976062","https://openalex.org/W2949605107","https://openalex.org/W2970483532","https://openalex.org/W2974968593","https://openalex.org/W2989281995"],"related_works":["https://openalex.org/W2116685558","https://openalex.org/W1981633543","https://openalex.org/W3084060419","https://openalex.org/W2108564014","https://openalex.org/W4380291663","https://openalex.org/W7128696771","https://openalex.org/W2012400980","https://openalex.org/W2561463182","https://openalex.org/W2058209525","https://openalex.org/W2402734028"],"abstract_inverted_index":{"Introductio":[0],"n":[1],".":[2],"Nowadays,":[3],"discovery":[4],"and":[5,50,75,141,165,183,190,203,212,225,233,286],"development":[6],"of":[7,19,35,44,62,90,98,122,130,156,221,238,240,258,270,294],"innovative":[8,28],"drugs":[9,21],"represent":[10],"a":[11,52,87,96,268],"relevant":[12],"goal":[13],"for":[14,54,109,253,278],"the":[15,33,83,119,123,128,174,255],"pharmaceutical":[16],"market.":[17],"One":[18],"such":[20],"is":[22],"N-(5-chloropyridine-2-yl)-2-({4-[ethanimidoyl(methyl)benzoyl}amino)-5-methylbenzamide":[23],"hydrochloride":[24],"(hereinafter":[25],"DD217),":[26],"an":[27],"drug":[29],"that":[30],"belongs":[31],"to":[32,48,69,161,290],"class":[34],"anticoagulants,":[36],"namely":[37],"factor":[38],"Xa":[39],"inhibitors.":[40],"Aim.":[41],"The":[42,103,152,235,248],"aim":[43],"this":[45],"study":[46],"was":[47,107,116,159,215,245,250,283],"develop":[49],"validate":[51],"method":[53,106,197,249,277],"DD217":[55,91,110,164,241,259,279,295],"determination":[56,111,280],"in":[57,82,112,169,198,242,261,281,288,297],"rat":[58,113,243,262,298],"plasma":[59,244,263,282],"by":[60,217],"means":[61],"high-performance":[63],"liquid":[64],"chromatography\u2013tandem":[65],"mass":[66],"spectrometry":[67],"(HPLC-MS/MS)":[68],"carry":[70],"out":[71],"pharmacokinetic":[72,256,292],"studies.":[73],"Materials":[74],"methods.":[76],"Outbred":[77],"Wistar":[78],"rats":[79],"were":[80,167,178,193],"used":[81],"study.":[84],"Rats":[85],"received":[86],"single":[88],"dose":[89,97,269],"substance":[92,260,296],"solution":[93,146],"intragastrically":[94],"at":[95,267],"5,":[99,271],"15,":[100,272],"30":[101,273],"mg/kg.":[102,274],"validated":[104,216,285],"HPLC-MS/MS":[105,276],"employed":[108],"plasma.":[114,299],"Nebivolol":[115],"chosen":[117],"as":[118],"internal":[120],"standard":[121],"method.":[124],"Chromatographic":[125],"separation":[126],"involved":[127],"use":[129],"Phenomenex":[131],"Luna":[132],"\u04218":[133],"column":[134],"(3":[135],"\u00b5m,":[136],"50":[137],"\u00d7":[138],"4.6":[139],"mm)":[140],"gradient":[142],"elution":[143],"with":[144],"water-acetonitrile":[145],"containing":[147],"0.1":[148],"%":[149],"formic":[150],"acid.":[151],"total":[153],"run":[154],"time":[155],"each":[157],"sample":[158],"equal":[160],"2.0":[162,246],"min.":[163],"nebivolol":[166],"detected":[168],"positive":[170],"electrospray":[171],"ionization":[172],"mode,":[173],"ion":[175],"transitions":[176],"monitored":[177],"m/z":[179],"436,1":[180],"\u2192":[181,185],"119,9":[182],"406,0":[184],"151,0,":[186],"respectively.":[187],"Pharmacokinetic":[188],"parameters":[189,257,293],"descriptive":[191],"statistics":[192],"calculated":[194],"through":[195],"model-independent":[196],"IBM":[199],"SPSS":[200],"Statistics":[201],"v27":[202],"Julia":[204],"v1.6.0":[205],"(MixedModels":[206],"v3.8.0,":[207],"ClinicalTrialUtilities":[208],"v0.5.1)":[209],"software.":[210],"Results":[211],"discussion.":[213],"Method":[214],"linearity,":[218],"lower":[219,236],"limit":[220,237],"quantification,":[222],"selectivity,":[223],"accuracy":[224],"precision,":[226],"dilution":[227],"integrity,":[228],"matrix":[229],"effect,":[230],"recovery,":[231],"carry-over,":[232],"stability.":[234],"quantification":[239],"ng/mL.":[247],"successfully":[251],"applied":[252,287],"establishing":[254],"after":[264],"intragastric":[265],"administration":[266],"Conclusion.":[275],"developed,":[284],"order":[289],"evaluate":[291]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2022-06-13T00:00:00"}
